HanAll Biopharma has received Orphan Drug Designation (ODD) from the Ministry of Health, Labor and W...

Iantrek Corporation has released promising results from its two-year clinical study on bio-reinforce...

China has approved SYCUME, the country’s first monoclonal antibody treatment for thyroid eye disease...

Stealth BioTherapeutics Inc. has achieved 50% of its enrollment target in the global Phase 3 ReNEW s...

Harrow, a North American eyecare pharmaceuticals company, has introduced VEVYE Access For All, a new...

...

A nationwide survey conducted by the Preservative Freedom Coalition highlights a critical gap in pat...

Topcon Healthcare, RadiusXR, and Glaukos have announced a strategic collaboration to launch Inspire,...

Harrow has finalized a 5-year strategic supply and development (SSD) agreement to ensure the continu...

Kodiak Sciences has successfully completed patient enrollment for its Phase 3 GLOW2 trial, evaluatin...